Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017

Cited by (812)

Items 101–200 of 812

1. Drugs for dyslipidaemia: the legacy effect of the Scandinavian Simvastatin Survival Study (4S)
   Timo E. Strandberg, Petri T. Kovanen, Donald M. Lloyd‐Jones, Frederick Johan Raal, Raul Dias Santos, Gerald Francis Watts · 2024 · The Lancet
2. Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study
   Shizuya Yamashita, Daisaku Masuda, Mariko Harada‐Shiba, Hidenori Arai, Hideaki Bujo, Shun Ishibashi, Hiroyuki Daida, Nobuhiko Koga, Shinichi Oikawa · 2021 · Journal of Atherosclerosis and Thrombosis
3. Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease: The Japan Epidemiology Collaboration on Occupational Health Study
   Huanhuan Hu, Ami Fukunaga, Toshitaka Yokoya, Tohru Nakagawa, Toru Honda, Shuichiro Yamamoto, Hiroko Okazaki, Toshiaki Miyamoto, Naoko Sasaki, Takayuki Ogasawara et al. · 2021 · Journal of Atherosclerosis and Thrombosis
4. Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery Disease
   Junnichi Ishii, Kosuke Kashiwabara, Yukio Ozaki, Hiroshi Takahashi, Fumihiko Kitagawa, Hideto Nishimura, Hideki Ishii, Satoshi Iimuro, Hideki Kawai, Takashi Muramatsu et al. · 2021 · Journal of Atherosclerosis and Thrombosis
5. Association between frequency of drinking alcohol and chronic kidney disease in men
   Yayoi Funakoshi, Hisamitsu Omori, Ayumi Onoue, 三原 修一, Yasuhiro Ogata, Takahiko Katoh · 2011 · Environmental Health and Preventive Medicine
6. Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial
   Shinji Koba, Ikuo Inoue, Marcoli Cyrille, Chen Lu, Hyoe Inomata, Junichiro Shimauchi, Kouji Kajinami · 2019 · Journal of Atherosclerosis and Thrombosis
7. White Blood Cell Count and C-Reactive Protein Independently Predicted Incident Diabetes: Yuport Medical Checkup Center Study
   Saori Kashima, Kazuo Inoue, Masatoshi Matsumoto, Kimihiko Akimoto · 2019 · Endocrine Research
8. Inflammatory cell infiltrates, hypoxia, vascularization, pentraxin 3 and osteoprotegerin in abdominal aortic aneurysms – A quantitative histological study
   Tereza Blassová, Zbyněk Tonar, Petr Tomášek, Petr Hošek, Ivana Hollan, Vladislav Třeška, Jiří Moláček · 2019 · PLoS ONE
9. Impact of sarcopenia on glycemic control and atherosclerosis in Japanese patients with type 2 diabetes: Cross‐sectional study using outpatient clinical data
   Shuhei Nakanishi, Masahiro Iwamoto, Hisanori Shinohara, Hideyuki Iwamoto, Hideaki Kaneto · 2020 · Geriatrics and gerontology international/Geriatrics & gerontology international
10. Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterol
    Teruo Jojima, Shintaro Sakurai, Sho Wakamatsu, Toshie Iijima, Masahiro Saito, Takuya Tomaru, Takahiko Kogai, Isao Usui, Yoshimasa Aso · 2021 · International Journal of Cardiology
11. Do we AGREE on the targets of antihypertensive drug treatment in older adults: a systematic review of guidelines on primary prevention of cardiovascular diseases
    Jonathan M. K. Bogaerts, Leonie M von Ballmoos, Wilco P. Achterberg, Jacobijn Gussekloo, Sven Streit, Milly A. van der Ploeg, Yvonne M. Drewes, Rosalinde K. E. Poortvliet · 2021 · Age and Ageing
12. Lipoprotein(a)-related cardiovascular and all-cause mortalities in Korean adults
    Byung Jin Kim, Mi Yeon Lee, Hyo‐In Choi, Min‐Jung Kwon, Jeonggyu Kang · 2022 · European Journal of Preventive Cardiology
13. JCS 2022 Guideline on Management and Re-Interventional Therapy in Patients With Congenital Heart Disease Long-Term After Initial Repair
    Hideo Ohuchi, Masaaki Kawata, Hideki Uemura, Teiji Akagi, Atsushi Yao, Hideaki Senzaki, Shingo Kasahara, Hajime Ichikawa, Hirohiko Motoki, Morio Syoda et al. · 2022 · Circulation Journal
14. Handgrip strength predicts new prediabetes cases among adults: A prospective cohort study
    Chrispin Mahala Manda, Takahiro Hokimoto, Tomohiro Okura, Hiroko Isoda, Hitoshi Shimano, Yukiko Wagatsuma · 2020 · Preventive Medicine Reports
15. Efficacy, Safety, and Pharmacokinetics of Inclisiran in Japanese Patients: Results from ORION-15
    Yamashita, Shizuya, Kiyosue, Arihiro, Maheux, Pierre, Mena-Madrazo, Jorge, Lesogor, Anastasia, Shao, Qing, Tamaki, Yuko, Nakamura, Hidekazu, Akahori, Mizuki, Kajinami, Kouji · 2024 · Journal of Atherosclerosis and Thrombosis
16. Depression and cardiovascular disease: mind the gap in the guidelines
    Dana Blatch Armon, Aliki Buhayer, Kapka Miteva, Gunther Meinlschmidt, Kevin Dobretz, Claudia Zuccarella‐Hackl, Christian Appenzeller‐Herzog, François Mach, Edouard J. Battegay · 2025 · European Heart Journal
17. Target of Triglycerides as Residual Risk for Cardiovascular Events in Patients With Coronary Artery Disease ― Post Hoc Analysis of the FMD-J Study A ―
    Masato Kajikawa, Tatsuya Maruhashi, Shinji Kishimoto, Shogo Matsui, Haruki Hashimoto, Yuji Takaeko, Farina Mohamad Yusoff, Yasuki Kihara, Kazuaki Chayama, Chikara Goto et al. · 2019 · Circulation Journal
18. Association between chronic kidney disease and new-onset dyslipidemia: The Japan Specific Health Checkups (J-SHC) study
    Takaaki Kosugi, Masahiro Eriguchi, Hisako Yoshida, Hikari Tasaki, Fumihiro Fukata, Masatoshi Nishimoto, Masaru Matsui, Ken‐ichi Samejima, Kunitoshi Iseki, Shouichi Fujimoto et al. · 2021 · Atherosclerosis
19. Dementia risk by combinations of metabolic diseases and body mass index: Japan Gerontological Evaluation Study Cohort Study
    Hiroshi Yokomichi, Katsunori Kondo, Yuiko Nagamine, Zentaro Yamagata, Naoki Kondo · 2019 · Journal of Diabetes Investigation
20. Low-Density Lipoprotein Cholesterol Level cannot be too Low: Considerations from Clinical Trials, Human Genetics, and Biology
    Hayato Tada, Soichiro Usui, Kenji Sakata, Masayuki Takamura, Masa‐aki Kawashiri · 2020 · Journal of Atherosclerosis and Thrombosis
21. A lower maximum bite force is a risk factor for developing cardiovascular disease: the Suita study
    Sakae Hashimoto, Takayuki Kosaka, Michikazu Nakai, Momoyo Kida, Shuri Fushida, Yoshihiro Kokubo, Makoto Watanabe, Aya Higashiyama, Kazunori Ikebe, Takahiro Ono et al. · 2021 · Scientific Reports
22. Health Information Exchange between Specialists and General Practitioners Benefits Rural Patients
    Masaharu Nakayama, Ryusuke Inoue, Satoshi Miyata, Hiroaki Shimizu · 2021 · Applied Clinical Informatics
23. Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events
    Masashi Sakuma, Satoshi Iimuro, Tomohiro Shinozaki, Takeshi Kimura, Yoshihisa Nakagawa, Yukio Ozaki, Hiroshi Iwata, Katsumi Miyauchi, Hiroyuki Daida, Satoru Suwa et al. · 2022 · BMC Medicine
24. Longitudinal association of hypertension and dyslipidemia with cognitive function in community-dwelling older adults: the SONIC study
    Yuko Nakamura, Mai Kabayama, Kayo Godai, Winston Tseng, Hiroshi Akasaka, Koichi I. Yamamoto, Yoichi Takami, Yasushi Takeya, Yasuyuki Gondo, Saori Yasumoto et al. · 2023 · Hypertension Research
25. Intracranial arterial wall enhancement using gadolinium-enhanced 3D black-blood T1-weighted imaging
    Koichi Takano, Kosuke Hida, Yasuo Kuwabara, Kengo Yoshimitsu · 2016 · European Journal of Radiology
26. Higher Blood Uric Acid in Female Humans and Mice as a Protective Factor against Pathophysiological Decline of Lung Function
    Haruka Fujikawa, Yuki Sakamoto, Natsuki Masuda, Kentaro Oniki, Shunsuke Kamei, Hirofumi Nohara, Ryunosuke Nakashima, Kasumi Maruta, Taisei Kawakami, Yuka Eto et al. · 2020 · Antioxidants
27. Association between Achilles tendon xanthoma and severity of coronary artery disease in patients undergoing percutaneous coronary intervention
    Hideki Kitahara, Takashi Nakayama, Yoshihide Fujimoto, Yoshio Kobayashi · 2020 · Journal of Cardiology
28. The importance of stroke as a risk factor of cognitive decline in community dwelling older and oldest peoples: the SONIC study
    2020
29. A Combination of Blood Pressure and Total Cholesterol Increases the Lifetime Risk of Coronary Heart Disease Mortality: EPOCH–JAPAN
    Michihiro Satoh, Takayoshi Ohkubo, Kei Asayama, Yoshitaka Murakami, Daisuke Sugiyama, Takashi Waki, Sachiko Tanaka‐Mizuno, Michiko Yamada, Shigeyuki Saitoh, Kiyomi Sakata et al. · 2020 · Journal of Atherosclerosis and Thrombosis
30. CAVI-Lowering Effect of Pitavastatin May Be Involved in the Prevention of Cardiovascular Disease: Subgroup Analysis of the TOHO-LIP
    Atsuhito Saiki, Yasuhiro Watanabe, Takashi Yamaguchi, Masahiro Ohira, Daiji Nagayama, Naoko Sato, Mizuho Kanayama, Mao Takahashi, Kazuhiro Shimizu, Masao Moroi et al. · 2020 · Journal of Atherosclerosis and Thrombosis
31. Nonrestorative sleep is a risk factor for metabolic syndrome in the general Japanese population
    Yuichiro Otsuka, Yoshitaka Kaneita, Katsutoshi Tanaka, Osamu Itani, Yoshiyuki Kaneko, Masahiro Suzuki, Yuuki Matsumoto, Kenichi Kuriyama · 2023 · Diabetology & Metabolic Syndrome
32. Fibrates and the risk of cardiovascular outcomes in chronic kidney disease patients
    Goto, Hirohito, Iseri, Ken, Hida, Noriko · 2024 · Nephrology Dialysis Transplantation
33. Systematic review of clinical guidelines for lipid lowering in the secondary prevention of cardiovascular disease events
    Rosemary Brown, Paul I. Welsh, Jennifer Logue · 2020 · Open Heart
34. Atherosclerotic Cardiovascular Disease Risk Prediction Models in China, Japan, and Korea
    Patricia Kim Phuong Nguyen, Dong Hui Zhao, Tomonori Okamura, Hyeon Chang Kim, Nathan D. Wong, Eugene Yang · 2025 · JACC Asia
35. Familial hypercholesterolemia in Southeast and East Asia
    Candace L. Jackson, Magdi Zordok, Iftikhar J. Kullo · 2021 · American Journal of Preventive Cardiology
36. Lipid Management and 2-Year Clinical Outcomes in Japanese Patients with Acute Coronary Syndrome: EXPLORE-J
    Masato Nakamura, Junya Ako, Hidenori Arai, Atsushi Hirayama, Atsushi Nohara, Yoshitaka Murakami, Asuka Ozaki, Mariko Harada‐Shiba · 2021 · Journal of Atherosclerosis and Thrombosis
37. A retrospective, cross-sectional study of real-world values of cardiovascular risk factors using a healthcare database in Japan
    Daisuke Shima, Yoichi Ii, Yuji Yamamoto, Satoshi Nagayasu, Yumiko Ikeda, Yoko Fujimoto · 2014 · BMC Cardiovascular Disorders
38. Nonalcoholic fatty liver disease is associated with both subcutaneous and visceral adiposity
    Takeshi Kure, Seiichi Mawatari, Yasushi Imamura, Kohei Oda, Kotaro Kumagai, Yasunari Hiramine, Hironori Miyahara, Shuji Kanmura, Akihiro Moriuchi, Hirofumi Uto et al. · 2019 · Medicine
39. Effects of HbA1c on the Development and Progression of Chronic Kidney Disease in Elderly and Middle-Aged Japanese: Iki Epidemiological Study of Atherosclerosis and Chronic Kidney Disease (ISSA-CKD)
    Tetsuhiko Yasuno, Toshiki Maeda, Kazuhiro Tada, Koji Takahashi, Kenji Ito, Yasuhiro Abe, Shigeaki Mukoubara, Kosuke Masutani, Hisatomi Arima, Hitoshi Nakashima · 2019 · Internal Medicine
40. Prevalence and treatment conditions for hypertension and dyslipidaemia complicated with systemic lupus erythematosus: A multi-centre cross-sectional study
    Mayu Saito, Nobuyuki Yajima, Ryo Yanai, Yumi Tsubokura, Kunihiro Ichinose, Ryusuke Yoshimi, Shigeru Ohno, Ken‐ei Sada · 2021 · Lupus
41. The Asia-Pacific Body Mass Index Classification and New-Onset Chronic Kidney Disease in Non-Diabetic Japanese Adults: A Community-Based Longitudinal Study from 1998 to 2023
    Yukari Okawa, Toshiharu Mitsuhashi, Toshihide Tsuda · 2025 · Biomedicines
42. The Lifelong Health Support 10: a Japanese prescription for a long and healthy life
    Ahmed Arafa, Yoshihiro Kokubo, Rena Kashima, Masayuki Teramoto, Yukie Sakai, Saya Nosaka, Youko M. Nakao, Emi Watanabe · 2022 · Environmental Health and Preventive Medicine
43. Hypertension and diabetes mellitus are associated with high FIB-4 index in a health checkup examination cohort without known liver disease
    Shunsuke Sato, Hidehiko Kawai, Sho Sato, Hirohiko Iwasaki, Masashi Omori, Yuji Kita, Yuji Ikeda, Takahito Awatsu, Ayato Murata, Gentaro Taniguchi et al. · 2022 · BMC Gastroenterology
44. Carotid Intima Media Thickness and Risk Factor for Atherosclerosis: Tohoku Medical Megabank Community-Based Cohort Study
    Masato Takase, Naoki Nakaya, Tomohiro Nakamura, Mana Kogure, Rieko Hatanaka, Kumi Nakaya, Ippei Chiba, Ikumi Kanno, Kotaro Nochioka, Naho Tsuchiya et al. · 2023 · Journal of Atherosclerosis and Thrombosis
45. Age-period-cohort Analysis of Healthy Lifestyle Behaviors Using the National Health and Nutrition Survey in Japan
    Tasuku Okui · 2020 · Journal of Preventive Medicine and Public Health
46. Worldwide Increasing Use of Nonfasting Rather Than Fasting Lipid Profiles
    Anne Langsted, Børge Grønne Nordestgaard · 2024 · Clinical Chemistry
47. A body shape index could serve to identify individuals with metabolic syndrome and increased arterial stiffness in the middle-aged population
    Tomonori Sugiura, Yasuaki Dohi, Yasuyuki Takagi, Takashi Yokochi, Naofumi Yoshikane, Kenji S. Suzuki, Takamasa Tomiishi, Takashi Nagami, Mitsunori Iwase, Hiroyuki Takase et al. · 2021 · Clinical Nutrition ESPEN
48. Impact of gut microbiome on dyslipidemia in japanese adults: Assessment of the Shika-machi super preventive health examination results for causal inference
    Yuna Miyajima, Shigehiro Karashima, Kazuhiro Ogai, Kouki Taniguchi, Kohei Ogura, Masaki Kawakami, Hidetaka Nambo, Mitsuhiro Kometani, Daisuke Aono, Masashi Demura et al. · 2022 · Frontiers in Cellular and Infection Microbiology
49. Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
    Shun Ishido, Nobuharu Tamaki, Yuka Takahashi, Naoki Uchihara, Keito Suzuki, Yuki Tanaka, Haruka Miyamoto, Michiko Yamada, Hiroaki Matsumoto, Tsubasa Nobusawa et al. · 2023 · BMC Gastroenterology
50. Validity of a Novel Method for Estimating Low-Density Lipoprotein Cholesterol Levels in Cardiovascular Disease Patients Treated with Statins
    Takeshi Sonoda, Takuro Takumi, Masaaki Miyata, Daisuke Kanda, Ippei Kosedo, Satoshi Yoshino, Mitsuru Ohishi · 2018 · Journal of Atherosclerosis and Thrombosis
51. Hyperuricaemia and vascular risk
    Matteo Landolfo, Claudio Borghi · 2019 · Current Opinion in Cardiology
52. Estimation of 10-Year Risk of Death from Coronary Heart Disease, Stroke, and Cardiovascular Disease in a Pooled Analysis of Japanese Cohorts: EPOCH-JAPAN
    Yuanying Li, Hiroshi Yatsuya, Sachiko Tanaka, Hiroyasu Iso, Akira Okayama, Ichiro Tsuji, Kiyomi Sakata, Yoshihiro Miyamoto, Hirotsugu Ueshima, Katsuyuki Miura et al. · 2020 · Journal of Atherosclerosis and Thrombosis
53. Risk Factors for Poor Outcome of Cervical Laminoplasty
    Masaaki Machino, Kei Ando, Kazuyoshi Kobayashi, Hiroaki Nakashima, Shunsuke Kanbara, Sadayuki Ito, Taro Inoue, Keigo Ito, Fumihiko Kato, Naoki Ishiguro et al. · 2020 · Spine
54. Hepatitis C virus infection causes hypolipidemia regardless of hepatic damage or nutritional state: An epidemiological survey of a large Japanese cohort
    Teruo Miyazaki, Akira Honda, Tadashi Ikegami, Yoshifumi Saitoh, Takeshi Thomas Hirayama, Takashi Hara, Mikio Doy, Yasushi Matsuzaki · 2011 · Hepatology Research
55. Hepatic inflammation and fibrosis are profiles related to mid‐term mortality in biopsy‐proven MASLD: A multicenter study in Japan
    Tsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, Yoshihiro Kamada, Hirokazu Takahashi, Miwa Kawanaka, Yoshio Sumida, Michihiro Iwaki, Hideki Hayashi, Hidenori Toyoda et al. · 2024 · Alimentary Pharmacology & Therapeutics
56. Omega-3 fatty acid ethyl esters improve low-density lipoprotein subclasses without increasing low-density lipoprotein-cholesterol levels: A phase 4, randomized study
    Daisaku Masuda, Yuko Miyata, Shingo Matsui, Shizuya Yamashita · 2019 · Atherosclerosis
57. The relationship between serum levels of LOX-1 ligand containing ApoAI as a novel marker of dysfunctional HDL and coronary artery calcification in middle-aged Japanese men
    Aya Hirata, Akemi Kakino, Tomonori Okamura, Yoko Usami, Yoshiko Fujita, Aya Kadota, Akira Fujiyoshi, Takashi Hisamatsu, Keiko Kondo, Hiroyoshi Segawa et al. · 2020 · Atherosclerosis
58. Prediabetes is associated with proteinuria development but not with glomerular filtration rate decline: A longitudinal observational study
    Mariko Furukawa, Takeshi Onoue, Kiminori Kato, Takashi Wada, Yukito Shinohara, Fumie Kinoshita, Motomitsu Goto, Hiroshi Arima, Kazuyo Tsushita · 2021 · Diabetic Medicine
59. Chronic Non-communicable Diseases: Risk Factors, Disease Burden, Mortalities and Control
    Ravi Kant Upadhyay · 2022 · Acta Scientific Medical Sciences
60. Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study
    Akihiro Nakamura, Yuta Kagaya, Hiroki Saito, Masanori Kanazawa, Kenjiro Sato, Masanobu Miura, Masateru Kondo, Hideaki Endo · 2022 · Journal of Atherosclerosis and Thrombosis
61. Healthy lifestyle, lipoprotein (a) levels and the risk of coronary artery disease
    Hayato Tada, Kan Yamagami, Kenji Sakata, Soichiro Usui, Masa‐aki Kawashiri, Masayuki Takamura · 2023 · European Journal of Clinical Investigation
62. Safety and efficacy of a 48-week long-term ingestion of D-allulose in subjects with high LDL cholesterol levels
    Misuzu Tanaka, Akane Kanasaki, Noriko Hayashi, Tetsuo Iida, Koji Murao · 2020 · Fundamental Toxicological Sciences
63. Effects of Nutrition Education Program for the Japan Diet on Serum LDL-Cholesterol Concentration in Patients with Dyslipidemia: A Randomized Controlled Trial
    Chizuko Maruyama, Yuri Shijo, Noriko Kameyama, Ariko Umezawa, Aisa Sato, Ai Nishitani, Makoto Ayaori, Katsunori Ikewaki, Masako Waki, Tamio Teramoto · 2021 · Journal of Atherosclerosis and Thrombosis
64. Effect of Anagliptin on Glycemic and Lipid Profile in Patients With Type 2 Diabetes Mellitus
    Yukari Chiba, Tadashi Yamakawa, Hirohisa Tsuchiya, Mari S. Oba, Daisuke Suzuki, Hirosuke Danno, Yoji Takatsuka, Hiroshi Shigematsu, Mizuki Kaneshiro, Yasuo Terauchi · 2018 · Journal of Clinical Medicine Research
65. The Role of Transcription Factors in Coronary Artery Disease and Myocardial Infarction
    Chunyan Luo, Yuwen Ruan, Peixue Sun, Haoran Wang, Weihua Yang, Yuankai Gong, Decheng Wang · 2022 · Frontiers in Bioscience-Landmark
66. Interaction of Blood Pressure and Glycemic Status in Developing Cardiovascular Disease: Analysis of a Nationwide Real‐World Database
    Yuta Suzuki, Hidehiro Kaneko, Yuichiro Yano, Akira Okada, Hidetaka Itoh, Satoshi Matsuoka, Isao Yokota, Takahiro Imaizumi, Katsuhito Fujiu, Nobuaki Michihata et al. · 2022 · Journal of the American Heart Association
67. The Impact of the Mediterranean Diet and Lifestyle Intervention on Lipoprotein Subclass Profiles among Metabolic Syndrome Patients: Findings of a Randomized Controlled Trial
    Beatriz Candás‐Estébanez, Bárbara Fernández‐Cidón, Emili Corbella, Cristian Tebé, Marta Fanlo‐Maresma, Virginia Esteve-Luque, Jordi Salas‐Salvadó, Montserrat Fitó, Antoni Riera‐Mestre, Emilio Ros et al. · 2024 · International Journal of Molecular Sciences
68. Effects of a fish-based diet and administration of pure eicosapentaenoic acid on brachial-ankle pulse wave velocity in patients with cardiovascular risk factors
    Yoshihiro Fukuoka, Norihito Nuruki, Shun Amiya, Katsunori Tofuku, Shinichiro Aosaki, Hirohito Tsubouchi · 2013 · Journal of Cardiology
69. High sex hormone-binding globulin concentration is a risk factor for high fibrosis-4 index in middle-aged Japanese men
    Yuya Fujihara, Nobuya Hamanoue, Hiromi Yano, Makito Tanabe, Yuko Akehi, Takashi Nomiyama, Toshihiko Yanase · 2019 · Endocrine Journal
70. Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects
    Jian‐Jun Li, Hui-Hui Liu, Na‐Qiong Wu, Khung Keong Yeo, K. C. B. Tan, Junya Ako, Rungroj Krittayaphong, Ru‐San Tan, Philip E. Aylward, Sang Hong Baek et al. · 2020 · Expert Opinion on Drug Metabolism & Toxicology
71. Comparison of clinical features and polysomnographic findings between men and women with sleep apnea.
    Shiho Yamakoshi, Takatoshi Kasai, Yasuhiro Tomita, Hisashi Takaya, Satoshi Kasagi, Masateru Kawabata, Koji Narui, Yasuhiro Setoguchi · 2016 · PubMed Central
72. Small-Dense Low-Density Lipoprotein Cholesterol: A Subclinical Marker for the Primary Prevention of Coronary Heart Disease
    Yoshihiro Kokubo, Makoto Watanabe, Aya Higashiyama, Kyoko Honda-Kohmo · 2020 · Journal of Atherosclerosis and Thrombosis
73. Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis
    Tsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, Yoshihiro Kamada, Yuichiro Suzuki, Koji Sawada, Miwa Tatsuta, Tatsuji Maeshiro, Hiroshi Tobita, Takemi Akahane et al. · 2025 · Journal of Gastroenterology
74. Alcohol drinking patterns have a positive association with cognitive function among older people: a cross-sectional study
    Yuya Akagi, Mai Kabayama, Yasuyuki Gondo, Yukie Masui, Saori Yasumoto, Nonglak Klinpudtan, Werayuth Srithumsuk, Kayo Godai, Kazunori Ikebe, Hiroshi Akasaka et al. · 2022 · BMC Geriatrics
75. Clinical and genetic features of sitosterolemia in Japan
    Hayato Tada, Nobuko Kojima, Kan Yamagami, Masayuki Takamura, Masa‐aki Kawashiri · 2022 · Clinica Chimica Acta
76. Protective role of perivascular adipose tissue in the cardiovascular system
    Yi Tong, Zheng Zuo, Xinqi Li, Minghua Li, Zhenggui Wang, Xiaoxue Guo, Xishu Wang, Ying Sun, Dongmei Chen, Zhiguo Zhang · 2023 · Frontiers in Endocrinology
77. Significance of Persistent Inflammation in Patients With Chronic Coronary Syndrome
    Hiroshi Iwata, Katsumi Miyauchi, Ryo Naito, Satoshi Iimuro, Yukio Ozaki, Ichiro Sakuma, Yoshihisa Nakagawa, Kiyoshi Hibi, Takefui Hiro, Yoshihiro Fukumoto et al. · 2024 · JACC Advances
78. Eicosapentaenoic acid therapy is associated with decreased coronary plaque instability assessed using optical frequency domain imaging
    Takao Konishi, Daisuke Sunaga, Naohiro Funayama, Tadashi Yamamoto, Hironori Murakami, Daisuke Hotta, Masanori Nojima, Shinya Tanaka · 2019 · Clinical Cardiology
79. Hypercholesterolemia and Lifetime Risk of Coronary Heart Disease in the General Japanese Population: Results from the Suita Cohort Study
    Daisuke Sugiyama, Tanvir Chowdhury Turin, Fahmida Yeasmin, Nahid Rumana, Makoto Watanabe, Aya Higashiyama, Misa Takegami, Yoshihiro Kokubo, Tomonori Okamura, Yoshihiro Miyamoto · 2019 · Journal of Atherosclerosis and Thrombosis
80. Decreased masticatory performance is related to increased intima-media thickness in a general urban Japanese population: The Suita study
    Momoyo Kida, Takahiro Ono, Yoshihiro Kokubo, Yoko Yoshimuta, Takayuki Kosaka, Miki Kikui, Masaaki Yamamoto, Kazunori Ikebe, Yoshinobu Maeda, Takashi Nokubi et al. · 2020 · Journal of Prosthodontic Research
81. Activating transcription factor 3 is a potential target and a new biomarker for the prognosis of atherosclerosis
    Weiwei Qin, Huiyu Yang, Gaizhen Liu, Rui Bai, Yunfei Bian, Zhiming Yang, Chuanshi Xiao · 2020 · Human Cell
82. Role of Lipid-Lowering Therapy in Low-Density Lipoprotein Cholesterol Goal Attainment: Focus on Patients With Acute Coronary Syndrome
    Qinqin Wang, Chun Liang · 2020 · Journal of Cardiovascular Pharmacology
83. Circulating Mature PCSK9 Level Predicts Diminished Response to Statin Therapy
    Naoto Kuyama, Yu Kataoka, Misa Takegami, Kunihiro Nishimura, Mariko Harada‐Shiba, Mika Hori, Masatsune Ogura, Fumiyuki Otsuka, Yasuhide Asaumi, Teruo Noguchi et al. · 2021 · Journal of the American Heart Association
84. Beta-3-adrenergic Receptor rs4994 Polymorphism Is a Potential Biomarker for the Development of Nonalcoholic Fatty Liver Disease in Overweight/Obese Individuals
    Yuki Sakamoto, K. Oniki, N. Kumagae, Kazunori Morita, Koji Otake, Y. Ogata, J. Saruwatari · 2019 · Disease Markers
85. Impact of hypertension stratified by diabetes on the lifetime risk of cardiovascular disease mortality in Japan: a pooled analysis of data from the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan study
    Yukiko Imai, Takumi Hirata, Shigeyuki Saitoh, Toshiharu Ninomiya, Yoshihiro Miyamoto, Hirofumi Ohnishi, Yoshitaka Murakami, Hiroyasu Iso, Sachiko Tanaka, Katsuyuki Miura et al. · 2020 · Hypertension Research
86. Low Free Triiodothyronine Level as a Predictor of Cardiovascular Events and All-Cause Mortality in Patients Undergoing Hemodialysis: The DREAM Cohort
    Yuko Yamazaki, Tetsuo Shoji, Masako Miyashima, Yuki Nagata, Yoshinori Kakutani, Akinobu Ochi, Tomoaki Morioka, Shinya Nakatani, Katsuhito Mori, Yoshihiro Tsujimoto et al. · 2020 · Journal of Atherosclerosis and Thrombosis
87. Prevalence of Chronic Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Retrospective Study Based on the National Health Insurance Service-National Health Screening Cohort in Korea, 2002~2015
    Haejung Lee, Misoon Lee, Gaeun Park, Ah Reum Khang · 2022 · Korean Journal of Adult Nursing
88. Age‐Dependent Relationship of Hypertension Subtypes With Incident Heart Failure
    Yuta Suzuki, Hidehiro Kaneko, Yuichiro Yano, Akira Okada, Hidetaka Itoh, Satoshi Matsuoka, Katsuhito Fujiu, Satoko Yamaguchi, Nobuaki Michihata, Taisuke Jo et al. · 2022 · Journal of the American Heart Association
89. Artificial intelligence in coronary artery calcium score: rationale, different approaches, and outcomes
    Gennari, Antonio G., Rossi, Alexia, De Cecco, Carlo N., van Assen, Marly, Sartoretti, Thomas, Giannopoulos, Andreas A., Schwyzer, Moritz, Huellner, Martin W., Messerli, Michael · 2024 · The International Journal of Cardiovascular Imaging
90. Salivary cortisol levels are associated with outcomes of weight reduction therapy in obese Japanese patients
    Akihiro Himeno, Noriko Satoh‐Asahara, Takeshi Usui, Hiromichi Wada, Mayu Tochiya, Shigeo Kono, Nobuko Yamada-Goto, Goro Katsuura, Koji Hasegawa, Kazuwa Nakao et al. · 2011 · Metabolism
91. SPPARM alpha: the Lazarus effect
    Jean‐Charles Fruchart, Raul Dias Santos · 2019 · Current Opinion in Lipidology
92. Inter-Arm Blood Pressure Difference in Diabetes Mellitus and Its Preferential Association with Peripheral Artery Disease
    Masako Miyashima, Tetsuo Shoji, Yoshinori Kakutani, Yuko Yamazaki, Akinobu Ochi, Tomoaki Morioka, Kayo Shinohara-Mitsuki, Shinya Fukumoto, Atsushi Shioi, Masaaki Inaba et al. · 2019 · Journal of Atherosclerosis and Thrombosis
93. Mortality of inactive hepatitis B virus carriers in Japan is similar to that of the general population
    Takashi Kumada, Hidenori Toyoda, Satoshi Yasuda, Takanori Ito, Junko Tanaka · 2021 · Hepatology Research
94. Population pharmacodynamic analysis of LDL ‐cholesterol lowering effects by statins and co‐medications based on electronic medical records
    Makoto Kakara, Hiroko Nomura, Masato Fukae, Keisuke Gotanda, Takeshi Hirota, Sunao Matsubayashi, Hideki Shimomura, Masaaki Hirakawa, Ichiro Ieiri · 2014 · British Journal of Clinical Pharmacology
95. Close Association between Subclinical Atherosclerosis and Pulmonary Function in Middle-Aged Male Smokers
    Tomonori Sugiura, Yasuaki Dohi, Yasuyuki Takagi, Takashi Yokochi, Naofumi Yoshikane, Kenji S. Suzuki, Takamasa Tomiishi, Takashi Nagami, Mitsunori Iwase, Hiroyuki Takase et al. · 2020 · Journal of Atherosclerosis and Thrombosis
96. Burden, risk factors, and projections of ischemic heart disease in China (1990–2021): findings from the 2021 GBD study
    San-Qing Xu, Zhiyang Liu, Mu Tang, Chunli Xu · 2025 · Frontiers in Cardiovascular Medicine
97. Efficacy of Statin/Ezetimibe for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Asian Populations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Akshaya Srikanth Bhagavathula, Wafa Ali Aldhaleei, Nadya Obaid Al Matrooshi, Jamal Rahmani · 2020 · Clinical Drug Investigation
98. Cardiovascular Risk Factor Burden and Treatment Control in Patients with Chronic Kidney Disease: A Cross-Sectional Study
    Hiromasa Kitamura, Shigeru Tanaka, Hiroto Hiyamuta, Sho Shimamoto, Kazuhiko Tsuruya, Toshiaki Nakano, Takanari Kitazono · 2022 · Journal of Atherosclerosis and Thrombosis
99. The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study)
    Yasutaka Takeda, Ichiro Sakuma, Shinya Hiramitsu, Mizuho Okada, Shinichiro Ueda, Masaru Sakurai · 2023 · Frontiers in Cardiovascular Medicine
100. Hepatitis C virus eradication by direct‐acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low‐density lipoprotein cholesterolemia without an increase in body weight
     Yoshimasa Tokuchi, Goki Suda, Naoki Kawagishi, Masatsugu Ohara, Risako Kohya, Takashi Sasaki, Tomoka Yoda, Osamu Maehara, Shunsuke Ohnishi, Akinori Kubo et al. · 2023 · Hepatology Research